United Therapeutics | UTHR - SCHULD

Aktienkurs
567.16
Täglich Wechseln
-5.69 -0.99%
Monatlich
4.72%
Jährlich
94.65%
Q2 Prognose
555.02




SCHULD Veränderung Datum
Amarin USD 0 0 2025-03
Ardelyx USD 207.61M 968K 2025-09
Baxter International USD 9.71B 13M 2025-09
Bayer EUR 39.39B 1.31B 2025-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 17.75B 396M 2025-09
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Insmed USD 727.89M 163.33M 2025-12
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
J&J USD 47.93B 2.14B 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Moderna USD 734M 7M 2025-09
Omeros USD 442.16M 199K 2023-09
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 2.71B 2.42B 2025-12
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09